EA

Eagle Veterinary Technology Co.,Ltd

Manufactures vet pharma for livestock/aquaculture & distributes premium pet food.

044960 | KO

Overview

Corporate Details

ISIN(s):
KR7044960003
LEI:
Country:
South Korea
Address:
충청남도 예산군 신암면 추사로 235-34, 예산군
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1970, Eagle Veterinary Technology Co., Ltd. is a specialized company in animal health, manufacturing and distributing veterinary pharmaceuticals and premium pet food. Its pharmaceutical division serves the livestock (cattle, swine, poultry) and aquaculture industries, offering a range of products including antibiotics, anthelmintics, and innovative bio-feeds developed through partnerships with global firms. The companion animal division, Haruwell, focuses on the premium market by distributing international brands like Now Fresh, Go! Solutions, and CARU, while also developing its own functional product lines such as the 'Probiomil' probiotic feed and 'SUMMIT' tailored nutrition diets. The company is committed to research and development to improve animal well-being and actively engages with its markets through industry seminars, consumer expos, and corporate social responsibility initiatives.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.0 MB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.0 MB
2025-03-19 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 20.9 KB
2025-03-11 00:00
Audit Report / Information
감사보고서제출
Korean 17.7 KB
2025-03-11 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 652.9 KB
2025-02-21 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 178.9 KB
2025-02-11 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 9.0 KB
2025-02-04 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정
Korean 8.7 KB
2024-11-14 00:00
Quarterly Report
분기보고서 (2024.09)
Korean 870.7 KB
2024-08-14 00:00
Interim Report
반기보고서 (2024.06)
Korean 864.9 KB
2024-05-16 00:00
Quarterly Report
분기보고서 (2024.03)
Korean 873.5 KB
2024-03-29 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 23.0 KB
2024-03-21 00:00
Audit Report / Information
사업보고서 (2023.12)
Korean 548.1 KB
2024-03-19 00:00
Audit Report / Information
감사보고서제출
Korean 17.7 KB
2024-03-11 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 166.2 KB

Automate Your Workflow. Get a real-time feed of all Eagle Veterinary Technology Co.,Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Eagle Veterinary Technology Co.,Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Eagle Veterinary Technology Co.,Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Tourmaline Bio, Inc. Logo
Develops an anti-IL-6 antibody for cardiovascular, inflammatory, and immune diseases.
United States of America
TRML
TOWA PHARMACEUTICAL CO.,LTD. Logo
Manufactures and markets high-quality, accessible generic drugs for various therapeutic areas.
Japan
4553
Transcode Therapeutics, Inc. Logo
Develops targeted RNA therapies for metastatic cancer using a proprietary nanoparticle delivery platform.
United States of America
RNAZ
Travere Therapeutics, Inc. Logo
Develops therapies for rare kidney and metabolic diseases, with an FDA-approved treatment for IgA nephropathy.
United States of America
TVTX
Traws Pharma, Inc. Logo
Develops oral small-molecule therapies for respiratory viral diseases and cancer.
United States of America
TRAW
TScan Therapeutics, Inc. Logo
Developing TCR-engineered T-cell therapies for solid and hematologic cancers.
United States of America
TCRX
TSUMURA & CO. Logo
A leader in Japanese Kampo herbal medicine, producing prescription and OTC formulations.
Japan
4540
TuHURA Biosciences, Inc./NV Logo
Phase 3 immuno-oncology firm developing therapeutics to overcome cancer therapy resistance.
United States of America
HURA
TURK İLAÇ VE SERUM SANAYİ A.Ş. Logo
Turkish producer of pharmaceuticals, specializing in IV solutions and vaccines for hospitals.
Türkiye
TRILC
Tvardi Therapeutics, Inc. Logo
Developing oral STAT3 inhibitors to treat cancers and fibrosis-driven diseases.
United States of America
TVRD

Talk to a Data Expert

Have a question? We'll get back to you promptly.